ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SNG Synairgen Plc

4.675
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.675 4.36 4.99 - 60,335 08:00:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.41M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.68p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.41 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 1526 to 1549 of 99175 messages
Chat Pages: Latest  67  66  65  64  63  62  61  60  59  58  57  56  Older
DateSubjectAuthorDiscuss
30/3/2020
16:26
Nobby - what are your thoughts on overall value upon successful result?
dave444
30/3/2020
16:25
Good find and written a day after the trial was granted.
tickboo
30/3/2020
16:24
Good to read that other NHS Trusts are proactively being added into the SNG-01 trials. Makes you wonder why they would be eh?!
tburns
30/3/2020
16:24
Absolutely there will be delayed trades popping up
awise355
30/3/2020
16:24
Great find!
awise355
30/3/2020
16:23
Westmoreland

Well spotted from 19th March

makendon
30/3/2020
16:23
Westmoreland

Yes, written on the 19th of March, so already underway. :o)

jev1
30/3/2020
16:22
I wonder if we pass 11m trades today?
dave444
30/3/2020
16:21
Thanks - getting confused with Trek I think ?
routy
30/3/2020
16:21
Administered through a nebuliser once a day.
jev1
30/3/2020
16:20
So I am not going crackers ----------
westmoreland lad
30/3/2020
16:18
No this is a drug not a ventilator...
nobbygnome
30/3/2020
16:17
On BBC news now
routy
30/3/2020
16:17
Is it SNGs device JVC and Dyson are going to manufacture?
routy
30/3/2020
16:16
Full on the offer at 63p due to pop up again here
tburns
30/3/2020
16:14
Thanks Nobby, again, much appreciated
hms_trader
30/3/2020
16:13
Can see us closing at 65p at this rate, both popped up a penny and buys flooding in
tburns
30/3/2020
16:10
Looks like both Offer and Bid due to rise again due to relentless buys. Peeps don't want to be out of this if an RN landed tomorrow at 7am
tburns
30/3/2020
16:02
>> hms

Yes that is what the biology would tell you......but as I say it is not that simple from a drug point of view. I of course am bullish here but always try to be balanced.

nobbygnome
30/3/2020
15:59
Lest we forget and also highlighted on LSE:

Bill Gates funds WHO with tens of $ Billions
Bill Gates refers in an interview a few days ago to the focus on the top three or four solutions to COV19
SNG is highlighted by WHO as one of the four possible solutions.
Bill Gates and Mark Zuckerberg also join forces to combat COV19

Synopsis:

SNG is in the spotlight at the top table where £ Billions are available for investment. :o)

jev1
30/3/2020
15:58
Do you think this will carrying on rising into the close, keeping the bid above 60p by close would be good and all being well build from there first thing tomorrow. What a +ve RNS on trial would do for the share price tomorrow is anyone's guess
tburns
30/3/2020
15:56
thanks Nobby, appreciate the response. Would you say Interferon Betas are better anti virals than Interferon Alphas?
hms_trader
30/3/2020
15:55
Hi Nobby re 10m shares traded - where does that data come from please?
makendon
30/3/2020
15:54
"LifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19. The aim is to run trials in patients during the current epidemic. It is anticipated that applications will be for funding to repurpose one or more drugs that are generic, already licensed, or are in late stage development for another indication."

Deadline for applications is 6th April with grant awards being announced in w/c 27th April, would like to think we've applied for this; shame the grant award date falls a couple of weeks after the conditional placing closes, but would provide further strategic leverage if the trials are successful / they need further cash to expand the size of the study...

74tom
Chat Pages: Latest  67  66  65  64  63  62  61  60  59  58  57  56  Older

Your Recent History

Delayed Upgrade Clock